Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations.
暂无分享,去创建一个
R. Schofield | A. Kippen | D. Higazi | E. Fonfria | S. Coward | Elizabeth Marks | Lisa-Marie Foulkes
[1] D. Stern,et al. Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology , 2019, Scientific Reports.
[2] K. Hanschmann,et al. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.
[3] D. Noort,et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients , 2018, Toxins.
[4] A. Pickett. Commentary: A Cell Line for Detection of Botulinum Neurotoxin Type B , 2018, Front. Pharmacol..
[5] A. Albanese,et al. Recent developments in clinical trials of botulinum neurotoxins. , 2018, Toxicon : official journal of the International Society on Toxinology.
[6] S. Samizadeh,et al. Botulinum neurotoxin formulations: overcoming the confusion , 2018, Clinical, cosmetic and investigational dermatology.
[7] J. Krupp,et al. The Expanding Therapeutic Utility of Botulinum Neurotoxins , 2018, Toxins.
[8] C. Montecucco,et al. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology , 2017, Pharmacological Reviews.
[9] G. Choi,et al. The Efficacy and Safety of Liquid-Type Botulinum Toxin Type A for the Management of Moderate to Severe Glabellar Frown Lines , 2015, Plastic and reconstructive surgery.
[10] W. Tucker,et al. Performance and mouse bioassay comparability of the BoCell™ A cell-based assay , 2013 .
[11] Shashi K. Sharma,et al. Botulinum neurotoxin: Where are we with detection technologies? , 2013, Critical reviews in microbiology.
[12] K. Aoki,et al. Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay , 2012, PloS one.
[13] Andreas Luch,et al. The Current Scientific and Legal Status of Alternative Methods to the LD50 Test for Botulinum Neurotoxin Potency Testing , 2010, Alternatives to laboratory animals : ATLA.
[14] Mauricio Montal,et al. Botulinum neurotoxin: a marvel of protein design. , 2010, Annual review of biochemistry.
[15] Edwin R Chapman,et al. Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Crawford,et al. Analysis of Quantal Response Data , 1994 .
[17] M. Manca,et al. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal. , 2018, Functional neurology.
[18] Sabine Pellett. Progress in cell based assays for botulinum neurotoxin detection. , 2013, Current topics in microbiology and immunology.